Primary Care Update

Today, and all COVID episode. Does adding baricitinib improve outcomes in patients on remdesivir; convalescent plasma given early in high risk elders; and how common are long-hauler symptoms.

This week, we will discuss screening for lung cancer, preventing celiac disease with early introduction of wheat, and a positive trial of convalescent plasma for COVID in patients with early infection. 

This week, we will discuss the HPV vaccine and whether it actually prevents invasive cervical cancer, diagnosing inflammatory bowel disease in children, and COVID infectivity in households and families. Plus a mythbusting quiz and John's recommendation for what NOT to read. 

This is an all-COVID-19 week. We discuss the WHO Solidarity trial of remdesivir and other antivirals, banlamivimab for outpatients, and an RCT of convalescent serum. 

This week we're joined by special guest Dr. Gary Ferenchick, friend of the pod and professor of Internal Medicine at THE Michigan State University. This week we discuss gabapentin for chronic pelvic pain, cast vs boot (vs surgery) for ruptured achilles tendon, and aspirin for primary prevention.

We cover 6 COVID-19 studies today, focusing on natural and acquired immunity, the tocilizumab trials, and a fishing story. Also the quiz, and you can get free CME at: https:// iafp.mclms.net

This week we will discuss treatment of overactive bladder syndrome, a smoking cessation guideline and bone density testing. For free CME, go to https://iafp.mclms.net. 

Since it has been several weeks since we discussed COVID, this week we will discuss tests for diagnosing it, children and adolescents, whether a vaccine will stop the pandemic, and symptom duration after contracting COVID.

This week, we discuss: influenza prophylaxis, treatment of scaphoid fractures and mortality associated with bariatric surgery. And now you can get free CME (0.5 hour) from the Illinois Academy of Family Physicians for listening. Just go to: iafp.mclms.net, answer a short quiz, and claim your credit.

This week John, Henry and Mark discuss dual antiplatelet therapy after stroke, updated recommendations for management of gout, and long-term follow up of hormone replacement for post menopausal women.

We review 9 more of the top COVID-19 research studies to date, including studies on transmission, treatment, and prognosis.

In this episode we summarize 9 top COVID-19 studies in a special episode prepared for the Indiana Academy of Family Physicians.

This week, we discuss hopefully the last two studies of hydroxychloroquine for patients with COVID (still doesn't work), pulmonary rehab in patients with COPD, and the use of special footwear in patients with knee DJD.

This week, a COVID-19 outbreak in an Israeli high school, the accuracy of antibody studies, denervation to treat hypertension, and identifying low-risk patients with syncope. Plus the quiz, and a recommendation. 

This week, an all COVID-19 episode covers 7 new studies in just 24 thrill-packed minutes: 2 phase 2 vaccine trials just out yesterday, outpatient monitoring of patients with COVID-19, hydroxychloroquine in mildly ill patients, and transmission of COVID-19 by children

This week we discuss COVID research on how many are asymptomatic and for how long people are infectious , managing overactive bladder symptoms in men, and perioperative probiotics and synbiotics for patients undergoing abdominal surgery.

2  COVID papers on seroprevalence and total vs confirmed cases, treating UTI with telehealth, migraine prophylaxis for kids, and variation in lab values.

This week, 6 COVID-19 updates: corticosteroids reduce mortality for sickest patients, non-drug approaches to controlling COVID, a review of the multisystem inflammatory syndrome in kids, another study on COVID 19 mortality and race, asymptomatic COVID and a report from the CDC on factors related to hospital and ICU use among patients with COVID-19.

This week on Primary Care Update: 2 COVID-19 studies (convalescent plasma RCT and accuracy of patient self-sampling), plus managing pneumothorax, and something that seems to work for infantile colic. 

A lot to cover: remdesivir updates, the effect of cancer treatment on COVID mortality, hypertensive medications, last call for HCQ, and racial disparities.

This week on primary care update: safety of convalescent sera, two social distancing studies, cellulitis diagnosis, and treating COPD exacerbations. Plus a bonus beer POEM.

This week: salivary testing for COVID, COVID immunity, ACR guidelines for managing patients with degenerative joint disease, and the use of old forms of insulin in managing patients with type 2 diabetes.

In episode 46 we again cover all things COVID-19: 2 trials of remdesivir, news on viral shedding, COVID mortality, thrombotic events and risk of infection among COVID contacts. You can get all of our research briefs on COVID-19 here: https://www.aafp.org/journals/afp/explore/covid-19-daily-briefs.html

This week, 2 new COVID-19 studies (doi:10.1001/jama.2020.6771 and doi: 10.1001/jama.2020.6775), an effective treatment for irritable bowel syndrome ( https://www.ncbi.nlm.nih.gov/pubmed/31852769 ), and trends in prostate cancer screening ( https://www.ncbi.nlm.nih.gov/pubmed/31794057 ).

This week, research updates about COVID-19: the largest trial to date of hydroxychloroquine ( https://doi.org/10.1101/2020.04.10.20060558 ), the first serosurvey results ( https://doi.org/10.1101/2020.04.14.20062463 ), doing telehealth ( www.bmj.com/content/368/bmj.m1182 ) , masks ( https://doi.org/10.17226/25776 ) , the effect of temperature ( https://doi.org/10.1101/2020.04.14.20062463 ) and vir...